Cargando…

MMP12 knockout prevents weight and muscle loss in tumor-bearing mice

BACKGROUND: Colorectal cancer is a malignant gastrointestinal cancer, in which some advanced patients would develop cancer cachexia (CAC). CAC is defined as a multi-factorial syndrome characterized by weight loss and muscle loss (with or without fat mass), leading to progressive dysfunction, thereby...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lingbi, Yang, Mingming, He, Shihui, Li, Zhengyang, Li, Haobin, Niu, Ting, Xie, Dehuan, Mei, Yan, He, Xiaodong, Wei, Lili, Huang, Pinzhu, Huang, Mingzhe, Zhang, Rongxin, Wang, Lijing, Li, Jiangchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642861/
https://www.ncbi.nlm.nih.gov/pubmed/34863141
http://dx.doi.org/10.1186/s12885-021-09004-y
Descripción
Sumario:BACKGROUND: Colorectal cancer is a malignant gastrointestinal cancer, in which some advanced patients would develop cancer cachexia (CAC). CAC is defined as a multi-factorial syndrome characterized by weight loss and muscle loss (with or without fat mass), leading to progressive dysfunction, thereby increasing morbidity and mortality. Apc(Min/+) mice develop spontaneous intestinal adenoma, which provides an established model of colorectal cancer for CAC study. Upon studying the Apc(Min/+) mouse model, we observed a marked decrease in weight gain beginning around week 15. Such a reduction in weight gain was rescued when Apc(Min/+) mice were crossed with MMP12(−/−) mice, indicating that MMP12 has a role in age-related Apc(Min/+)-associated weight loss. As a control, the weight of MMP12(−/−) mice on a weekly basis, their weight were not significantly different from those of WT mice. METHODS: Apc(Min/+); MMP12(−/−) mice were obtained by crossing Apc(Min/+) mice with MMP12 knockout (MMP12 (−/−)) mice. Histological scores were assessed using hematoxylin-eosin (H&E) staining. MMP12 expression was confirmed by immunohistochemistry and immunofluorescence staining. ELISA, protein microarrays and quantitative Polymerase Chain Reaction (qPCR) were used to investigate whether tumor could up-regulate IL-6. Cell-based assays and western blot were used to verify the regulatory relationship between IL-6 and MMP12. Fluorescence intensity was measured to determine whether MMP12 is associated with insulin and insulin-like growth factor 1 (IGF-1) in vitro. MMP12 inhibitors were used to explore whether MMP12 could affect the body weight of Apc(Min/+) mice. RESULTS: MMP12 knockout led to weight gain and expansion of muscle fiber cross-sectional area (all mice had C57BL/6 background) in Apc(Min/+) mice, while inhibiting MMP12 could suppress weight loss in Apc(Min/+) mice. MMP12 was up-regulated in muscle tissues and peritoneal macrophages of Apc(Min/+) mice. IL-6 in tumor cells and colorectal cancer patients is up-regulation. IL-6 stimulated MMP12 secretion of macrophage. CONCLUSIONS: MMP12 is essential for controlling body weight of Apc (Min/+) mice. Our study shows that it exists the crosstalk between cancer cells and macrophages in muscle tissues that tumor cells secrete IL-6 inducing macrophages to up-regulate MMP12. This study may provide a new perspective of MMP12 in the treatment for weight loss induced by CAC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-09004-y.